J. Gómez-Sirvent

Risk of clinically significant depression in HIV‐infected patients: effect of antiretroviral drugs

F. Vidal, F. Gutiérrez, M. Masiá, 2014, HIV medicine.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

D. Podzamczer, B. Clotet, J. Romeu, 1999, AIDS.

Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

G. Marcaida, J. Niubó, V. Cuervas-Mons, 2019, The Journal of antimicrobial chemotherapy.

HTLV testing of solid organ transplant donors

J. Miro, E. Poveda, S. Sauleda, 2019, Clinical transplantation.

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

J. Miro, E. Poveda, S. Sauleda, 2019, Open forum infectious diseases.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

A. Cruceta, J. Mallolas, M. Laguno, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.

M. Leal, M. Leal, F. Vidal, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 years.

D. Podzamczer, J. Mallolas, M. Leal, 2012, Current HIV research.

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

B. Clotet, J. Romeu, A. Cruceta, 2000, Journal of acquired immune deficiency syndromes.